Trial Profile
Phase I trial of nitisinone [SYN118] as adjunctive therapy in patients with advanced Parkinson's disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2010
Price :
$35
*
At a glance
- Drugs Nitisinone (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Synosia Therapeutics
- 29 Sep 2010 Results were presented at the World Parkinson Congress, according to a Synosia media release.
- 29 Sep 2010 New trial record